Series 5 Episode 2 - Transforming Cancer Diagnostics with Liquid Biopsies: Insights from an NHS Molecular Pathology Laboratory

Welcome to Genomics Now, a podcast series where you can learn how genomics is developing in England's NHS. This podcast series is recorded in 2024 and is part of the North Thames Genomic Medicine Services Educational Toolkit. In each bite-sized episode, we explore what is changing in genomics. We answer the questions on genomics we've been asked by different healthcare professionals, discuss how genomics may impact various healthcare roles, and examine how genomics can be used to successfully improve patient care.

In this episode, Dr. Shazia Mahamdallie chats with Professor Mike Hubank, Scientific Director of Clinical Genomics at the Royal Marsden NHS Trust and Scientific Director of the North Thames Genomics Laboratory Hub. They explore the process of transferring technology into NHS laboratories, focusing on the pilot of liquid biopsy circulating tumour DNA testing.

Learn how this cutting-edge technology is revolutionising lung cancer diagnostics, the benefits of the collaboration with Guardant Health, and the potential for expanding liquid biopsy testing across various cancer types. Discover the future implications and the significant impact on patient care.

Tune in for an enlightening discussion on the integration of advanced genomics in healthcare and its promising future.

For more resources and updates on genomic-based clinical developments and research, visit the North Thames Genomic Medicine Service website. If you enjoyed this episode, share your thoughts and spread the word on social media by tagging the North Thames Genomic Medicine Service.